Zantac cancer risk: Heartburn drug pulled from shelves over cancer fears

ZANTAC and other ranitidine products have been pulled from shelves after US retailer CVS suspended the sale of the heartburn drug to investigate links to cancer.
Daily Express :: Life and Style Feed